| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
First Ever Professional Practice Guidelines For Psychedelic-Assisted Therapy Published
Clinical-stage psychedelics biotech Reunion Neuroscience (NASDAQ: REUN) and MPM BioImpact have completed their announced plan o...
Minneapolis Mayor Deprioritizes Psychedelics: 'We Should Be In The Business Of Helping People' Minneapolis Mayor Jac...
As Reunion Neuroscience (NASDAQ: REUN) and Mindset Pharma (OTCMKTS: MSSTF) continue their court battle over claims on a novel 4...
Clinical-stage psychedelics company Reunion Neuroscience (NASDAQ: REUN) is about to close on its take-private transaction with ...
https://www.marijuanamoment.net/california-psilocybin-legalization-campaign-cleared-to-collect-signatures-for-2024-ballot-initi...
https://www.marijuanamoment.net/bipartisan-lawmakers-push-for-marijuana-and-psychedelics-amendments-to-defense-bill-but-committ...
World's Largest Psychedelics Conference Boasts 12K Attendees
Clinical-stage psychedelics firm Reunion Neuroscience Inc. (NASDAQ: REUN) reported fiscal results for the fourth quarter and ye...
